Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors

Journal of Medicinal Chemistry

Volumn 54, Issue 15, 2011, Pages 5362-5372

  Wang, Wei ^a   Cui, Jinquan ^a   Lu, Xiaoxia ^a   Padakanti, Prashanth K ^a   Xu, Jinbin ^a   Parsons, Stanley M ^b   Luedtke, Robert R ^c   Rath, Nigam P ^d   Tu, Zhude ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CARBONYL DERIVATIVE; FLUORINE 18; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

ARTICLE; BINDING AFFINITY; DRUG IDENTIFICATION; DRUG SELECTIVITY; DRUG SYNTHESIS; IN VITRO STUDY;

ANIMALS; GUINEA PIGS; HUMANS; PC12 CELLS; PIPERIDINES; RATS; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 79961245186     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200203f     Document Type: Article

References (50)

1. Martin, W. R.; Eades, C. G.; Thompson, J. A.; Huppler, R. E.; Gilbert, P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 1976, 197, 517-532
2. Chang, K. J.; Cuatrecasas, P. Heterogeneity and properties of opiate receptors Fed. Proc. 1981, 40, 2729-2734 (Pubitemid 12193921)
3. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junien, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T. P.; Tam, S. W.; Taylor, D. P. A proposal for the classification of sigma binding sites Trends Pharmacol. Sci. 1992, 13, 85-86
4. Antonini, V.; Prezzavento, O.; Coradazzi, M.; Marrazzo, A.; Ronsisvalle, S.; Arena, E.; Leanza, G. Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats J. Neurochem. 2009, 109, 744-754
5. Aydar, E.; Onganer, P.; Perrett, R.; Djamgoz, M. B.; Palmer, C. P. The expression and functional characterization of sigma (σ) 1 receptors in breast cancer cell lines Cancer Lett. 2006, 242, 245-257 (Pubitemid 44488625)
6. Kekuda, R.; Prasad, P. D.; Fei, Y. J.; Leibach, F. H.; Ganapathy, V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1) Biochem. Biophys. Res. Commun. 1996, 229, 553-558 (Pubitemid 27029069)
7. Abate, C.; Mosier, P. D.; Berardi, F.; Glennon, R. A. A structure-affinity and comparative molecular field analysis of sigma-2 (sigma(2)) receptor ligands Cent. Nerv. Syst. Agents Med. Chem. 2009, 9, 246-257
8. Deutsch, S. I.; Weizman, A.; Goldman, M. E.; Morihisa, J. M. The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy Clin. Neuropharmacol. 1988, 11, 105-119 (Pubitemid 18094784)
9. Aydar, E.; Palmer, C. P.; Djamgoz, M. B. Sigma receptors and cancer: possible involvement of ion channels Cancer Res. 2004, 64, 5029-5035 (Pubitemid 39006512)
10. 1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy J. Chem. Neuroanat. 2000, 20, 375-387 (Pubitemid 32162893)
11. Bourrie, B.; Bribes, E.; Derocq, J. M.; Vidal, H.; Casellas, P. Sigma receptor ligands: applications in inflammation and oncology Curr. Opin. Invest. Drugs 2004, 5, 1158-1163 (Pubitemid 39545284)
12. Bowen, W. D. Sigma receptors: recent advances and new clinical potentials Pharm. Acta Helv. 2000, 74, 211-218 (Pubitemid 30182572)
13. Ayata, C. Spreading depression: from serendipity to targeted therapy in migraine prophylaxis Cephalalgia 2009, 29, 1097-1114
14. Entrena, J. M.; Cobos, E. J.; Nieto, F. R.; Cendán, C. M.; Gris, G.; Del Pozo, E.; Zamanillo, D.; Baeyens, J. M. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice Pain 2009, 143, 252-261
15. Díaz, J. L.; Zamanillo, D.; Corbera, J.; Baeyens, J. M.; Maldonado, R.; Pericàs, M.; Vela, J. M.; Torrens, A. Selective sigma-1 (sigma(1)) receptor antagonists: emerging target for the treatment of neuropathic pain Cent. Nerv. Syst. Agents Med. Chem. 2009, 9, 172-183
16. Fishback, J. A.; Robson, M. J.; Xu, Y. T.; Matsumoto, R. R. Sigma receptors: potential targets for a new class of antidepressant drug Pharmacol. Ther. 2010, 127, 271-282
17. 1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability Bioorg. Med. Chem. 2009, 17, 3630-3641
18. Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer's disease Lancet 2006, 368, 387-403 (Pubitemid 44108123)
19. Matsumoto, R. R. Targeting sigma receptors: novel medication development for drug abuse and addiction Expert Rev. Clin. Pharmacol. 2009, 2, 351-358
20. Volz, H. P.; Stoll, K. D. Clinical trials with sigma ligands Pharmacopsychiatry 2004, 37, 5214-5220
21. Kunitachi, S.; Fujita, Y.; Ishima, T.; Kohno, M.; Horio, M.; Tanibuchi, Y.; Shirayama, Y.; Iyo, M.; Hashimoto, K. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors Brain Res. 2009, 1279, 189-196
22. Maurice, T.; Su, T.-P. The pharmacology of sigma-1 receptors Pharmacol. Ther. 2009, 124, 195-206
23. Ogawa, K.; Shiba, K.; Akhter, N.; Yoshimoto, M.; Washiyama, K.; Kinuya, S.; Kawai, K.; Mori, H. Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy Cancer Sci. 2009, 100, 2188-2192
24. John, C. S.; Bowen, W. D.; Varma, V. M.; McAfee, J. G.; Moody, T. W. Sigma receptors are expressed in human non-small cell lung carcinoma Life Sci. 1995, 56, 2385-2392
25. Vilner, B. J.; John, C. S.; Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines Cancer Res. 1995, 55, 408-413
26. 125I]BP: a potential σ receptor marker for human prostate tumors Nucl. Med. Biol. 1998, 25, 189-194 (Pubitemid 28172445)
27. 1 receptor probes Appl. Radiat. Isot. 2010, 68, 459-465
28. Brent, P. J.; Pang, G. T. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture Eur. J. Pharmacol. 1995, 278, 151-160
29. 1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs Neoplasia 2007, 9, 358-369 (Pubitemid 46799979)
30. Spruce, B. A.; Campbell, L. A.; McTavish, N.; Cooper, M. A.; Appleyard, V. L.; O'Neill, M.; Howie, J.; Samson, J.; Watt, S.; Murray, K.; McLean, D.; Leslie, N. R.; Safrany, S. T.; Ferguson, M. J.; Peters, J. A.; Prescott, A. R.; Box, G.; Hayes, A.; Nutley, B.; Raynaud, F.; Downes, C. P.; Lambert, J. J.; Thompson, A. M.; Eccles, S. Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo Cancer Res. 2004, 64, 4875-4886 (Pubitemid 38924532)
31. Hellewell, S. B.; Bowen, W. D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain Brain Res. 1990, 527, 244-253 (Pubitemid 20289511)
32. Georg, A.; Friedl, A. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma × rat glioma hybrid cell line NG108-15 J. Pharmacol. Exp. Ther. 1991, 259, 479-483
33. Hayashi, T.; Su, T. P. An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand Expert Opin. Ther. Targets 2008, 12, 45-58 (Pubitemid 351247161)
34. Mégalizzi, V.; Decaestecker, C.; Debeir, O.; Spiegl-Kreinecker, S.; Berger, W.; Lefranc, F.; Kast, R. E.; Kiss, R. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines Eur. J. Cancer 2009, 45, 2893-2905
35. Bhuiyan, M. S.; Tagashira, H.; Shioda, N.; Fukunaga, K. Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions Expert Opin. Ther. Targets 2010, 14, 1009-1022
36. Collier, T. L.; Waterhouse, R. N.; Kassiou, M. Imaging sigma receptors: applications in drug development Curr. Pharm. Des. 2007, 13, 51-72 (Pubitemid 46085300)
37. 18F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy) methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors Nucl. Med. Biol. 2006, 33, 211-215
38. 18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET Nucl. Med. Biol. 1997, 24, 127-134 (Pubitemid 27147918)
39. 18F]FPS Nucl. Med. Biol. 2003, 30, 555-563 (Pubitemid 36780957)
40. Ishikawa, M.; Hashimoto, K. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases J. Recept., Ligand Channel Res. 2010, 3, 25-36
41. 11C]SA4503 Int. J. Neuropsychopharmacol. 2009, 12, 1127-1131
42. Costantino, L.; Gandolfi, F.; Sorbi, C.; Franchini, S.; Prezzavento, O.; Vittorio, F.; Ronsisvalle, G.; Leonardi, A.; Poggesi, E.; Brasili, L. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands J. Med. Chem. 2005, 48, 266-273 (Pubitemid 40105265)
43. Efange, S. M. N.; Mach, R. H.; Smith, C. R.; Khare, A. B.; Foulon, C.; Akella, S. K.; Childers, S. R.; Parsons, S. M. Vesamicol analogues as sigma ligands: molecular determinants of selectivity at the vesamicol receptor Biochem. Pharmacol. 1995, 49, 791-797
44. 11C]SA4503 Nucl. Med. Biol. 2006, 33, 543-548 (Pubitemid 44251039)
45. 18F](+)-4- fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates Synapse 1997, 25, 368-380 (Pubitemid 27155148)
46. Efange, S. M. N.; Khare, A. B.; von Hohenberg, K.; Mach, R. H.; Parsons, S. M.; Tu, Z. Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter J. Med. Chem. 2010, 53, 2825-2835
47. 2 receptor-based imaging agents Nucl. Med. Biol. 1993, 20, 777-794 (Pubitemid 23233472)
48. 50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
49. 3 dopamine receptor ligands J. Med. Chem. 2011, 54, 1555-1564
50. 2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys J. Pharmacol. Exp. Ther. 2003, 306, 301-309 (Pubitemid 36734385)